Author: lbadmin

Nigeria gets nod to host African Energy Bank

Nigeria has been granted the hosting right for the African Energy Bank (AEB), after beating Ghana, Benin Republic, Algeria, South Africa and Cote D’Ivoire in a keenly contested bidding.

Sen. Heineken Lokpobiri, the Minister of State, Petroleum Resour…

Security agencies apprehend 2,678 suspects in June

The Strategic Communication Interagency Policy Committee (SCIPC), says the law enforcement agencies have apprehended 2,678 suspects for various offences across the country in June.

SCIPC is a committee of the spokespersons for the military, police, i…

RMAFC seeks closer ties with EFCC to recover loss revenue

The Revenue Mobilisation Allocation and Fiscal Commission (RMAFC), has advocated stronger collaboration with the Economic and Financial Crimes Commission (EFCC), to ensure recovery of unremitted revenues to the appropriate government coffers.

The Cha…

NNPCL, Shell JV partners donate IT centre to Bauchi versity

The Nigeria National Petroleum Company Limited (NNPCL), in collaboration with its partners has donated an ultramodern Information and Communication Technology (ICT) centre to the Sa’adu Zungur University, Bauchi.

The project was being implemented in …

Stakeholders urge FG to discourage importation of LPG cylinders

Stakeholders in the oil and gas sector have called for the review of the zero per cent import duties on the importation of Liquefied Petroleum Gas (LPG) cylinders, to encourage local production.

The stakeholders, who spoke in seperate interviews with…

FG mulls indigenous blockchain technology dev’t

The Federal Government has announced plans to develop a home grown blockchain technology to ensure protection of the national database for enhance security.

Malam Kashifu Inuwa, Director-General, National Information Technology Development Agency (NI…

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]